Viewing Study NCT07096869


Ignite Creation Date: 2025-12-24 @ 11:04 PM
Ignite Modification Date: 2025-12-29 @ 2:50 PM
Study NCT ID: NCT07096869
Status: RECRUITING
Last Update Posted: 2025-07-31
First Post: 2025-07-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bioequivalence Study of Paclitaxel Protein-bound Particles for Injectable Suspension (Albumin-bound) in Breast Cancer Patients
Sponsor: CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module